99 related articles for article (PubMed ID: 745806)
1. [Study of blood viscosity and fibrinogen as a guide to the therapy of atherosclerotic peripheral arteriopathy].
Savi I; Pola P
Minerva Med; 1978 Dec; 69(63):4401-10. PubMed ID: 745806
[TBL] [Abstract][Full Text] [Related]
2. Blood rheology changes during bezafibrate treatment.
Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
[TBL] [Abstract][Full Text] [Related]
3. [Increase in erythrocyte and plasma viscosity in patients with atherosclerotic vasculopathy of different sites].
Craveri A; Tornaghi G; Paganardi L; Di Bella M; Gallo E; Stanzani M
Minerva Med; 1987 Jun; 78(12):815-22. PubMed ID: 3601129
[TBL] [Abstract][Full Text] [Related]
4. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
[TBL] [Abstract][Full Text] [Related]
5. Blood and plasma viscosity in experimentally induced hyper- and hypo-fibrinogenaemia.
Pola P; Flore R; Tondi P
Int J Tissue React; 1986; 8(4):333-6. PubMed ID: 2943690
[TBL] [Abstract][Full Text] [Related]
6. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Jaeger BR; Labarrere CA
Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
[TBL] [Abstract][Full Text] [Related]
7. Correlation between hemorheologic parameters and carotid atherosclerosis in stroke.
Mercuri M; Orecchini G; Susta A; Tazza D; Ciuffetti G
Angiology; 1989 Apr; 40(4 Pt 1):283-6. PubMed ID: 2650579
[TBL] [Abstract][Full Text] [Related]
8. Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.
Jaeger BR
Ther Apher; 2001 Jun; 5(3):207-11. PubMed ID: 11467757
[TBL] [Abstract][Full Text] [Related]
9. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J
Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
[TBL] [Abstract][Full Text] [Related]
10. [Rheologic observations on blood viscosity in atherosclerosis (with dyslipidosis and peripheral obliterating arteriopathy)].
Alberto S; Biasci R; Naldi R; Picco S; Dughera L
Minerva Cardioangiol; 1977; 25(7-8):629-35. PubMed ID: 927655
[No Abstract] [Full Text] [Related]
11. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
[No Abstract] [Full Text] [Related]
12. [Plasma viscosity in atherosclerotic patients].
Turczyński B; Sroczyński J; Kossmann S
Pol Tyg Lek; 1976 Aug; 31(33):1423-5. PubMed ID: 62351
[No Abstract] [Full Text] [Related]
13. [Hemorrheologic disorders in obese patients. Study of the viscosity of the blood, erythrocytes, plasma, fibrinogen and the erythrocyte filtration index].
Craveri A; Tornaghi G; Paganardi L; Ranieri R; Leonardi G; Di Bella M
Minerva Med; 1987 Jul; 78(13):899-906. PubMed ID: 3601135
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis.
Ciuffetti G; Lombardini R; Pirro M; Lupattelli G; Mannarino E
Clin Hemorheol Microcirc; 2001; 25(1):31-9. PubMed ID: 11790868
[TBL] [Abstract][Full Text] [Related]
15. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
[TBL] [Abstract][Full Text] [Related]
16. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
[TBL] [Abstract][Full Text] [Related]
17. [Hemorheological aspects in relation to age and to the presence of arteriosclerotic disease].
Neirotti M; Molaschi M; Pernigotti L; Milla A; Fabris F
Ric Clin Lab; 1989; 19 Suppl 1():69-74. PubMed ID: 2629090
[No Abstract] [Full Text] [Related]
18. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Grzegorczyn S
Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):700-3. PubMed ID: 1669136
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals and in patients with chronic artery disease.
Patrassi GM; Veronesi A; Sartori MT; Viero ML; Boeri G; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):369-76. PubMed ID: 1703105
[TBL] [Abstract][Full Text] [Related]
20. Rheological and clotting changes in the immediate post-myocardial infarction period.
Patrassi GM; Brunetti A; de Zio A; Gribaldo A; Cafiero F; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):140-9. PubMed ID: 6164609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
